Pages that link to "Item:Q4696421"
From MaRDI portal
The following pages link to Estimating the Probability of Toxicity at the Recommended Dose Following a Phase I Clinical Trial in Cancer (Q4696421):
Displaying 6 items.
- Continual reassessment and related dose-finding designs (Q903292) (← links)
- Adaptive clinical trial designs for phase I cancer studies (Q2452091) (← links)
- Theoretical study of the continual reassessment method (Q2492919) (← links)
- Dose-Finding Designs for HIV Studies (Q3078854) (← links)
- A new design of the continual reassessment method (Q5082671) (← links)
- A system for determining maximum tolerated dose in clinical trial (Q5880093) (← links)
